Xia, Lin et al 24 also conducted a meta-analysis, which included 36 RCTs with a total of 11,126 patients comparing the effect of 8 GLP-1RAs on weight loss in patients with T2DM
Then, in January 2025, she teamed up with the telehealth company Ro, which her husband, Alexis Ohanian, is an investor in and board member of, to receive Zepbound
Among these potential key players, Roche continues to stand out with multiple obesity candidates within its pipeline, all in phase II trials (as of November 2025), and it is expected to enter the market in 2029 or later
Always confirm current pricing and state availability directly with the provider before starting treatment
By reducing inflammation, it might help with chronic conditions such as arthritis and tendinopathy
How quickly is my order dispatched and delivered